Company Overview
About Biobot Analytics
Biobot Analytics is a public health infrastructure company that uses wastewater epidemiology to provide early warning of infectious disease outbreaks, substance use trends, and other public health indicators to communities, public health agencies, and the federal government. Founded in 2017 by MIT graduates Mariana Matus and Newsha Ghaeli, the company became nationally prominent during the COVID-19 pandemic when its wastewater surveillance network provided some of the earliest data on SARS-CoV-2 spread in communities — often detecting outbreaks 4–7 days before clinical case reports.
Business Model & Competitive Advantage
Biobot operates the nation's largest wastewater disease surveillance network, processing samples from hundreds of wastewater treatment plants across all 50 states. The company's scientific methodology involves extracting and concentrating pathogen genetic material (RNA or DNA) from wastewater influent, then applying qPCR and sequencing techniques to quantify pathogen concentrations and identify variants. These measurements provide population-level health intelligence that is fundamentally different from individual clinical testing: wastewater captures signal from asymptomatic individuals, people who don't seek testing, and entire communities simultaneously.
Competitive Landscape 2025–2026
Beyond COVID-19, Biobot's platform tracks influenza, RSV, mpox, emerging variants, and illicit drug metabolites (tracking fentanyl and other opioid use at the community level). The CDC has partnered with Biobot as a core component of the National Wastewater Surveillance System (NWSS) established during the pandemic — institutionalizing wastewater epidemiology as a permanent public health monitoring tool. Biobot has raised $30M+ in venture funding and revenue from government contracts, public health agencies, and increasingly, pharmaceutical companies seeking real-world disease prevalence data.
Open Positions
Reddit Discussions
Key Differentiators
Strong Challenger
Biobot Analytics is an established challenger with significant market presence and competitive offerings in Government Tech.
Frequently Asked Questions
Not So Random Others
Zeffy
Zeffy is a Montreal-based fundraising platform for nonprofit organizations that charges zero platform fees on donations — asking donors to optionally contribute a tip to cover Zeffy's operating costs
Oda Studio
Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal
Cursor
Cursor is an AI-powered code editor built on Visual Studio Code that integrates advanced language models to provide intelligent code completion, generation, debugging, and refactoring capabilities dir
Kindful
Kindful is a donor management and fundraising platform designed for nonprofit organizations to manage relationships, track donations, and execute fundraising campaigns. The company serves small to mid
Armilla AI
Armilla AI is a third-party AI quality assurance and warranty company that evaluates AI models for organizations deploying AI in regulated or high-stakes contexts — assessing models against EU AI Act
Campfire
Campfire is a United States-based AI-native enterprise resource planning (ERP) company — backed by Y Combinator (S23) with $38.5 million raised including a $35 million Series A led by Accel in June 20
Compare Biobot Analytics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Biobot Analytics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Biobot Analytics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Biobot Analytics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →